Cargando…

Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors

Background. With the life expectancy of people living with HIV (PLHIV) rapidly approaching that of the general population, cardiovascular health in this group is as relevant as ever. Adenovirus 36 (Adv36) is one of the few viruses suspected to be a causative factor in promoting obesity in humans, ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapuła, Mariusz, Suchacz, Magdalena, Kozłowska, Joanna, Cybula, Aneta, Siwak, Ewa, Krankowska, Dagny, Wiercińska-Drapało, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412590/
https://www.ncbi.nlm.nih.gov/pubmed/36016261
http://dx.doi.org/10.3390/v14081639
_version_ 1784775531689934848
author Sapuła, Mariusz
Suchacz, Magdalena
Kozłowska, Joanna
Cybula, Aneta
Siwak, Ewa
Krankowska, Dagny
Wiercińska-Drapało, Alicja
author_facet Sapuła, Mariusz
Suchacz, Magdalena
Kozłowska, Joanna
Cybula, Aneta
Siwak, Ewa
Krankowska, Dagny
Wiercińska-Drapało, Alicja
author_sort Sapuła, Mariusz
collection PubMed
description Background. With the life expectancy of people living with HIV (PLHIV) rapidly approaching that of the general population, cardiovascular health in this group is as relevant as ever. Adenovirus 36 (Adv36) is one of the few viruses suspected to be a causative factor in promoting obesity in humans, yet there is a lack of data on this infection in PLHIV. Methods. PLHIV on stable suppressive antiretroviral therapy were included in the study, with assessment of anthropometric measures, blood pressure, serum lipid levels, fasting serum glucose and insulin, non-classical serum cardiovascular risk markers related to inflammation (hsCRP, resistin, calprotectin), and anti-Adv36 antibodies during a routine check-up. Results. 91 participants were recruited, of which 26.4% were Adv36-seropositive (Adv36(+)). Compared to Adv36-seronegative (Adv36(−)) controls, Adv36(+) individuals had a lower waist circumference (Adv36(+) 89.6 ± 7.7 cm, Adv36(−) 95.5 ± 11.7 cm, p = 0.024) and a lower waist-to-hip ratio (Adv36(+) 0.88 ± 0.06, Adv36(−) 0.92 ± 0.09, p = 0.014), but this did not reach statistical significance in the multivariate analysis (p > 0.05). Adv36(+) participants were less likely to be on lipid-lowering treatment (Adv36(+) 12.5%, Adv36(−) 34.3%, p = 0.042), even after adjustment for relevant baseline characteristics (OR = 0.23, 95%CI = 0.04–0.91), but no differences in cholesterol or triglyceride levels were found. No other statistically significant associations were observed. Conclusions. We found no evidence to support the claim that past Adv36-infection is associated with an increased prevalence of cardiovascular risk factors or with elevated inflammatory markers in PLHIV. More research is needed to replicate these findings in other samples of PLHIV and to compare them with the HIV-negative population.
format Online
Article
Text
id pubmed-9412590
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94125902022-08-27 Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors Sapuła, Mariusz Suchacz, Magdalena Kozłowska, Joanna Cybula, Aneta Siwak, Ewa Krankowska, Dagny Wiercińska-Drapało, Alicja Viruses Article Background. With the life expectancy of people living with HIV (PLHIV) rapidly approaching that of the general population, cardiovascular health in this group is as relevant as ever. Adenovirus 36 (Adv36) is one of the few viruses suspected to be a causative factor in promoting obesity in humans, yet there is a lack of data on this infection in PLHIV. Methods. PLHIV on stable suppressive antiretroviral therapy were included in the study, with assessment of anthropometric measures, blood pressure, serum lipid levels, fasting serum glucose and insulin, non-classical serum cardiovascular risk markers related to inflammation (hsCRP, resistin, calprotectin), and anti-Adv36 antibodies during a routine check-up. Results. 91 participants were recruited, of which 26.4% were Adv36-seropositive (Adv36(+)). Compared to Adv36-seronegative (Adv36(−)) controls, Adv36(+) individuals had a lower waist circumference (Adv36(+) 89.6 ± 7.7 cm, Adv36(−) 95.5 ± 11.7 cm, p = 0.024) and a lower waist-to-hip ratio (Adv36(+) 0.88 ± 0.06, Adv36(−) 0.92 ± 0.09, p = 0.014), but this did not reach statistical significance in the multivariate analysis (p > 0.05). Adv36(+) participants were less likely to be on lipid-lowering treatment (Adv36(+) 12.5%, Adv36(−) 34.3%, p = 0.042), even after adjustment for relevant baseline characteristics (OR = 0.23, 95%CI = 0.04–0.91), but no differences in cholesterol or triglyceride levels were found. No other statistically significant associations were observed. Conclusions. We found no evidence to support the claim that past Adv36-infection is associated with an increased prevalence of cardiovascular risk factors or with elevated inflammatory markers in PLHIV. More research is needed to replicate these findings in other samples of PLHIV and to compare them with the HIV-negative population. MDPI 2022-07-27 /pmc/articles/PMC9412590/ /pubmed/36016261 http://dx.doi.org/10.3390/v14081639 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sapuła, Mariusz
Suchacz, Magdalena
Kozłowska, Joanna
Cybula, Aneta
Siwak, Ewa
Krankowska, Dagny
Wiercińska-Drapało, Alicja
Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
title Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
title_full Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
title_fullStr Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
title_full_unstemmed Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
title_short Adenovirus 36 Infection in People Living with HIV—An Epidemiological Study of Seroprevalence and Associations with Cardiovascular Risk Factors
title_sort adenovirus 36 infection in people living with hiv—an epidemiological study of seroprevalence and associations with cardiovascular risk factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412590/
https://www.ncbi.nlm.nih.gov/pubmed/36016261
http://dx.doi.org/10.3390/v14081639
work_keys_str_mv AT sapułamariusz adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors
AT suchaczmagdalena adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors
AT kozłowskajoanna adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors
AT cybulaaneta adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors
AT siwakewa adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors
AT krankowskadagny adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors
AT wiercinskadrapałoalicja adenovirus36infectioninpeoplelivingwithhivanepidemiologicalstudyofseroprevalenceandassociationswithcardiovascularriskfactors